New hope for Tough-to-Treat blood cancers: Two-Drug combo shows promise

NCT ID NCT05005442

Summary

This study tested a new combination of two immunotherapy drugs (pembrolizumab and vibostolimab) for people with advanced blood cancers that had returned or stopped responding to other treatments. The main goals were to check the safety of the treatment and see how well it worked to shrink or control the cancer. Researchers measured how many people responded to the treatment and how long those responses lasted.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aarhus Universitetshospital, Skejby-Blodsygdomme ( Site 0362)

    Aarhus, Central Jutland, 8200, Denmark

  • Almazov National Medical Research Centre-Intensive care unit No. 10 for oncohematological patients (

    Saint Petersburg, Leningradskaya Oblast', 197341, Russia

  • Ankara University Hospital Cebeci ( Site 0561)

    Ankara, 06100, Turkey (Türkiye)

  • Azienda Ospedaliera Spedali Civili di Brescia-Hemathology ( Site 0400)

    Brescia, Lombardy, 25123, Italy

  • BC Cancer Vancouver ( Site 0034)

    Vancouver, British Columbia, V5Z 4E6, Canada

  • Chang Gung Medical Foundation-Linkou Branch ( Site 0262)

    Taoyuan District, 333, Taiwan

  • Chang Gung Memorial Hospital at Kaohsiung ( Site 0263)

    Kaohsiung Niao Sung Dist, Kaohsiung, 83301, Taiwan

  • Cherkasy Regional Oncology Dispensary ( Site 0593)

    Cherkassy, Cherkasy Oblast, 18009, Ukraine

  • City of Hope Comprehensive Cancer Center-Hematology ( Site 0024)

    Duarte, California, 91010, United States

  • Clinica Universidad de Navarra ( Site 0444)

    Pamplona, Navarre, 31008, Spain

  • Debreceni Egyetem Klinikai Kozpont-Belgyógyászati Klinika (Haematologia) ( Site 0402)

    Debrecen, 4032, Hungary

  • Dokuz Eylül Üniversitesi-Hematology ( Site 0563)

    Izmir, 35340, Turkey (Türkiye)

  • Ege University Medicine of Faculty ( Site 0565)

    Bornova, İzmir, 35100, Turkey (Türkiye)

  • FALP-UIDO ( Site 0623)

    Santiago, Region M. de Santiago, 6900941, Chile

  • Fondazione Policlinico Universitario Agostino Gemelli-ISTITUTO DI EMATOLOGIA ( Site 0383)

    Rome, Lazio, 00168, Italy

  • GBUZ Republican Clinical Oncological Dispensary-Antitumor drug therapy department ( Site 0548)

    Ufa, Baskortostan, Respublika, 450054, Russia

  • Gustave Roussy-DITEP ( Site 0301)

    Villejuif, Paris, 94800, France

  • Hadassah Medical Center ( Site 0522)

    Jerusalem, 9112001, Israel

  • Henry Ford Hospital ( Site 0003)

    Detroit, Michigan, 48202, United States

  • Hospital Universitario Fundación Jiménez Díaz-Oncology & Hematology ( Site 0446)

    Madrid, 28040, Spain

  • Hospital Universitario de Salamanca-Hematology ( Site 0441)

    Salamanca, 37007, Spain

  • Institute of Transfusion Medicine and Blood of the National Academy of Medical Sciences of Ukraine (

    Lviv, Lviv Oblast, 79044, Ukraine

  • Instituto Catalan de Oncologia - Hospital Duran i Reynals-Haematology Department ( Site 0442)

    L'Hospitalet Del Llobregat, Barcelona, 08908, Spain

  • Instituto Nacional del Cancer ( Site 0626)

    Chile, Region M. de Santiago, 8380455, Chile

  • Instituto do Câncer e Transplante de Curitiba ( Site 0611)

    Curitiba, Paraná, 80510130, Brazil

  • Jewish General Hospital ( Site 0032)

    Montreal, Quebec, H3T 1E2, Canada

  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0004)

    Hackensack, New Jersey, 07601, United States

  • Klinikum Mutterhaus der Borromäerinnen-Innere Medizin I ( Site 0325)

    Trier, Rhineland-Palatinate, 54290, Germany

  • Liga Norte Riograndense Contra o Câncer-Centro de Pesquisa Clínica ( Site 0601)

    Natal, Rio Grande do Norte, 59075-740, Brazil

  • MEDICAL COLLEGE OF WISCONSIN ( Site 0016)

    Milwaukee, Wisconsin, 53226, United States

  • McGill University Health Centre ( Site 0037)

    Montreal, Quebec, H4A 3J1, Canada

  • Medical Oncology Associates, PS ( Site 0001)

    Spokane, Washington, 99208, United States

  • Mega Medipol-Hematology ( Site 0567)

    Istanbul, 34214, Turkey (Türkiye)

  • Moscow City Clinical Hospital S.P. Botkin ( Site 0547)

    Moscow, Moscow, 125284, Russia

  • Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 0427)

    Gliwice, Silesian Voivodeship, 44-101, Poland

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Układu Chłonnego ( S

    Warsaw, Masovian Voivodeship, 02-781, Poland

  • National Cancer Institute ( Site 0585)

    Kyiv, Kyivska Oblast, 03022, Ukraine

  • National Research Center for Radiation Medicine of National Academy of Medical Sciences of Ukraine (

    Kyiv, Ukraine

  • Ondokuz Mayıs Universitesi ( Site 0564)

    Samsun, 55139, Turkey (Türkiye)

  • Országos Onkológiai Intézet-HEMATOLÓGIA ÉS LYMPHOMA OSZTÁLY KEMOTERÁPIA A ( Site 0405)

    Budapest, Pest County, 1122, Hungary

  • Ospedale San Raffaele-Unità Linfomi ( Site 0382)

    Milan, Lombardy, 20132, Italy

  • Pitie Salpetriere University Hospital-Clinical haematology ( Site 0304)

    Paris, 75013, France

  • Policlinico S. Orsola- Malpighi-Istituto di Ematologia "L. e A. Seragnoli" ( Site 0381)

    Bologna, 40138, Italy

  • Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0031)

    Toronto, Ontario, m5g2m9, Canada

  • Pécsi Tudományegyetem Klinikai Központ-I.sz. Belgyógyászati Klinika Hematológia ( Site 0401)

    Pécs, Baranya, 7624, Hungary

  • Rambam Health Care Campus ( Site 0526)

    Haifa, 3109601, Israel

  • Rigshospitalet-Hematology - CTU ( Site 0361)

    Copenhagen, Capital Region, 2100, Denmark

  • Russian Scientific Research Institute of Hematology and Blood Transfusion-Hematology ( Site 0542)

    Saint Petersburg, Sankt-Peterburg, 191024, Russia

  • Rutgers Cancer Institute of New Jersey ( Site 0023)

    New Brunswick, New Jersey, 08901, United States

  • Semmelweis University-Belgyógyászati és Hematológiai Klinika ( Site 0403)

    Budapest, 1088, Hungary

  • Sheba Medical Center-Hemato Oncology ( Site 0524)

    Ramat Gan, 5262100, Israel

  • Soroka Medical Center-Hematology Department ( Site 0523)

    Beersheba, 8410101, Israel

  • Sourasky Medical Center ( Site 0525)

    Tel Aviv, 64239, Israel

  • Universitaetsklinikum Essen ( Site 0327)

    Essen, North Rhine-Westphalia, 45122, Germany

  • Universitaetsklinikum Hamburg-Eppendorf-II. medical clinic ( Site 0332)

    Hamburg, 20246, Germany

  • Universitaetsklinikum Koeln-Klinik I für Innere Medizin ( Site 0321)

    Cologne, North Rhine-Westphalia, 50937, Germany

  • University of Chicago Medical Center ( Site 0005)

    Chicago, Illinois, 60637, United States

  • University of Colorado Anschutz Medical Campus-The Center for Cancer and Blood Disorders ( Site 0021

    Aurora, Colorado, 80045, United States

  • University of Texas MD Anderson Cancer Center ( Site 0014)

    Houston, Texas, 77030, United States

  • Universitätsklinikum Leipzig ( Site 0328)

    Leipzig, Saxony, 04103, Germany

  • Universitätsklinikum Marburg ( Site 0333)

    Marburg, Hesse, 35033, Germany

  • Uniwersytecki Szpital Kliniczny-Klinika Hematologii, Nowotworow Krwi i Transplantacji Szpiku ( Site

    Wrocaw, Lower Silesian Voivodeship, 50-556, Poland

  • Uniwersyteckie Centrum Kliniczne-Klinika Hematologii i Transplantologii ( Site 0424)

    Gdansk, Pomeranian Voivodeship, 80-214, Poland

  • Vehbi Koc Vakfi - Amerikan Hastanesi ( Site 0562)

    Istanbul, 34365, Turkey (Türkiye)

  • centre hospitalier lyon sud-Service Hématologie ( Site 0300)

    Pierre-Bénite, Rhone, 69310, France

Conditions

Explore the condition pages connected to this study.